SAGE THERAPEUTICS INC (SAGE)
US78667J1088 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 172.65M | 70.99M | 162.70M | 294.20M | 1.66B | |||
| Marketable Securities | 544.36M | 682.19M | 1.11B | 1.45B | 438.50M | |||
| Receivables | 14.11M | 88.61M | 13.70M | 18.50M | N/A | |||
| Inventories | N/A | 1.50M | N/A | N/A | N/A | |||
| Other Current Assets | 24.32M | 26.06M | 50.80M | 39.80M | 22.80M | |||
| Total Current Assets | 755.44M | 869.35M | 1.34B | 1.80B | 2.12B | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.44M | 6.38M | 13.40M | 19.10M | 31.80M | |||
| Other Non-Current Assets | 7.72M | 6.55M | 6.00M | 5.50M | 5.10M | |||
| Total Non-Current Assets | 12.16M | 12.93M | 19.40M | 24.70M | 36.80M | |||
| TOTAL ASSETS | 767.60M | 882.28M | 1.36B | 1.83B | 2.16B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 44.14M | 63.84M | 37.60M | 26.70M | 23.90M | |||
| Accounts Payable | 6.48M | 10.32M | 19.00M | 10.50M | 3.70M | |||
| Other Current Liabilities | 11.18M | 8.59M | 42.70M | 48.00M | 39.60M | |||
| Total Current Liabilities | 61.80M | 82.75M | 99.30M | 85.20M | 67.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | 0.00 | 4.60M | 11.10M | 19.70M | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 4.60M | 11.10M | 19.70M | |||
| TOTAL LIABILITIES | 61.80M | 82.75M | 103.90M | 96.30M | 86.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.68B | -2.57B | -2.03B | -1.50B | -1.04B | |||
| Additional Paid In Capital | 3.39B | 3.37B | 3.29B | 3.23B | 3.11B | |||
| Common Shares | 6.00K | 6.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -400.00K | -400.00K | -400.00K | -400.00K | -400.00K | |||
| Other Shareholders' Equity | -787.00K | -814.00K | -10.20M | -2.70M | 400.00K | |||
| Shares Outstanding | 60.18M | 60.04M | 59.50M | 58.90M | 58.30M | |||
| Tangible Book Value per Share | 11.73 | 13.32 | 21.05 | 29.35 | 35.55 | |||
| Total Shareholders' Equity | 705.80M | 799.53M | 1.25B | 1.73B | 2.07B | |||
| TOTAL LIABILITIES AND EQUITY | 767.60M | 882.28M | 1.36B | 1.83B | 2.16B | |||
| Statistics | ||||||||
| Current Ratio | 12.22 | 10.51 | 13.46 | 21.13 | 31.58 | |||
| Return On Assets (ROA) | -65.54% | -61.37% | -39.28% | -25.09% | 28.07% | |||
| Return On Equity (ROE) | -71.28% | -67.73% | -42.54% | -26.48% | 29.25% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 23.56% | |||
All data in USD